Estimating cure and risk of death from other causes of adolescent and young adult cancer patients in Europe.
Botta L, Capocaccia R, Vener C, Bernasconi A, Trama A, Didoné F, Demuru E, De Angelis R, Rossi S, Mousavi SM, Peters F, Bennet D, Mayer-da-Silva A, Jooste V; EUROCARE-6 WG. European Journal of Cancer 2025; 222:115443. doi: 10.1016/j.ejca.2025.115443.
Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000-2013: Results from EUROCARE-6, a population-based study.
Trama A, Geerdes EE, Demuru E, De Angelis R, Karim-Kos HE, Troussard X, Bennett D, Marcos-Gragera R, Kuehni CE, Liu H, Bernasconi A, Vener C, Guevara M, Zwaan CM, Mayer-da-Silva A, Paapsi K, Ragusa R, Smith OP; EUROCARE-6 Working Group. European Journal of Cancer 2025; 222:115336. doi: 10.1016/j.ejca.2025.115336.
Incidence and survival of rare female genital tract cancers in Europe: The EUROCARE-6 study.
Gatta G, Calleja-Agius J, Sandrucci S, Bennet D, Azzopardi MJ, Capocaccia R; EUROCARE WG. European Journal of Surgical Oncology 2025; 51(4):109996. doi: 10.1016/j.ejso.2025.109996.
Prognosis of Breast Cancer in European female adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results.
Bernasconi A, Toss A, Zattarin E, Mousavi SM, Blum M, Kuehni CE, Katalinic A, Trallero J, Rapiti E, Maso LD, Botta L, Rossi S, Peccatori F, Trama A; EUROCARE-6 Working Group. Breast 2025; 82:104472. doi: 10.1016/j.breast.2025.104472.
Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study.
Vener C, Lillini R, De Angelis R, Bonfarnuzzo S, Poirel HA, Trama A, Visser O, Troussard X, Marcos-Gragera R, Maynadié M, Demuru E, Di Benedetto C, Johannesen TB, Solans M, Paapsi K, Guevara M, Mousavi SM, Blum M, Von Moos R, Bennett D, Ragusa R, Guilloteau A, McShane CM, Rossi S, Sant M; EUROCARE-6 Working Group. European Journal of Cancer 2025; 220:115231. doi: 10.1016/j.ejca.2025.115231.
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 results.
Trama A, Lasalvia P, Stark D, McCabe MG, van der Graaf W, Gaspar N, Metayer L, Strauss SJ, Ragusa R, Guevara M, Bennett D, Dal Maso L, Batllés AMV, Schindera C, Mousavi SM, Cerza F, Botta L, Ferrari A, Provenzano S; EUROCARE-6 Working Group. European Journal of Cancer 2025; 217:115212. doi: 10.1016/j.ejca.2024.115212.
Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study.
Trama A, Bernasconi A, Cañete A, Carulla M, Daubisse-Marliac L, Rossi S, De Angelis R, Sanvisens A, Katalinic A, Paapsi K, Went P, Mousavi M, Blum M, Eberle A, Lamy S, Capocaccia R, Didonè F, Botta L; EUROCARE-6 WG. European Journal of Cancer 2025; 214:115147. doi: 10.1016/j.ejca.2024.115147.
Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results.
Indini A, Didoné F, Massi D, Puig S, Casadevall JR, Bennett D, Katalinic A, Sanvisens A, Ferrari A, Lasalvia P, Demuru E, Ragusa R, Mayer-da-Silva A, Blum M, Mousavi M, Kuehni C, Mihor A, Mandalà M, Trama A; EUROCARE-6 Working Group. European Journal of Cancer 2024; 213:115079. doi: 10.1016/j.ejca.2024.115079. Erratum in: European Journal of Cancer 2025; 218:115295. doi: 10.1016/j.ejca.2025.115295.
Survival and Health Care Burden of Children With Retinoblastoma in Europe.
Virgili G, Capocaccia R, Botta L, Bennett D, Hadjistilianou T, Innos K, Karim-Kos H, Kuehni CE, Kuhnel U, Mazzini C, Canete Nieto A, Paapsi K, Parravano M, Ronckers CM, Rossi S, Stiller C, Vicini G, Visser O, Gatta G; EUROCARE-6 Working Group. JAMA Ophthalmology 2024; 142(11):1062–70. doi: 10.1001/jamaophthalmol.2024.4140.
Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers.
Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Maso LD, Lepage C, Molinié F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V; EUROCARE-6 WG. European Journal of Cancer 2024; 208:114187. doi: 10.1016/j.ejca.2024.114187.
Survival of European adolescents and young adults diagnosed with cancer in 2010-2014.
Trama A, Botta L, Stiller C, Visser O, Cañete-Nieto A, Spycher B, Bielska-Lasota M, Katalinic A, Vener C, Innos K, Marcos-Gragera R, Paapsi K, Guevara M, Demuru E, Mousavi SM, Blum M, Eberle A, Ferrari A, Bernasconi A, Lasalvia P; EUROCARE-6 Working Group. European Journal of Cancer 2024; 202:113558. doi: 10.1016/j.ejca.2024.113558.
Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.
Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadié M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, Sánchez MJ, De Angelis R; EUROCARE-6 Working Group. Lancet Oncology 2024; 25(6):731-743. doi: 10.1016/S1470-2045(24)00141-4.
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study.
De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S; EUROCARE-6 Working Group. Lancet Oncology 2024; 25(3):293-307. doi: 10.1016/S1470-2045(23)00646-0.
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes.
Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R; EUROCARE-6 Working Group. Frontiers in Oncology 2023; 13, Article 1114701. doi: 10.3389/fonc.2023.1114701.
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study.
Botta L, Gatta G, Capocaccia R, Stiller C, Cañete A, Dal Maso L, Innos K, Mihor A, Erdmann F, Spix C, Lacour B, Marcos-Gragera R, Murray D, Rossi S; EUROCARE-6 Working Group. Lancet Oncology 2022; 23(12):1525-1536. doi: 10.1016/S1470-2045(22)00637-4.
Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials.
Vener C, Rossi S, Minicozzi P, Marcos-Gragera R, Poirel HA, Maynadié M, Troussard X, Pravettoni G, De Angelis R, Sant M; EUROCARE-6 Working Group. Frontiers in Oncology 2022; 12, Article 892684. doi: 10.3389/fonc.2022.892684.
